Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Child Neurology
•
Neuro-immunology
What criteria do you use to differentiate between MOGAD and MS in pediatric patients?
Related Questions
In a patient with strong serologic evidence of SLE presenting with isolated bilateral lower limb sensorimotor neuropathy, normal neuroimaging, and CSF, would you initiate cyclophosphamide with pulse-dose steroids upfront, or reserve escalation (e.g., plasma exchange or immunosuppressants) for cases refractory to steroids?
How do pediatric functional neurologic disorders differ from adult disorders in their presentation and diagnosis?
What is the diagnostic approach and management for suspected Hashimoto Encephalitis?
Which patients will have earlier diagnosis of multiple sclerosis via the new 2024 McDonald Criteria?
How do you decide when to pursue genetic testing for cerebral palsy?
How do you discontinue ketogenic diets previously used as a treatment for epilepsy?
When, if ever, do you use therapeutic hypothermia (targeted temperature management) in a non-neotal pediatric cardiac arrest patient?
When would you use ofatumumab for anti-NMDAR autoimmune encephalitis?
How does choice of enzyme replacement therapy and monitoring parameters for late-onset Pompe disease differ from infantile onset disease?
When do you consider cannabidiol for treatment of epilepsy?
